ACP-PA dividend yield: 4.00%. PFE dividend yield: 6.77%. ACP-PA is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ACP-PA shares. Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
ACP-PA is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ACP-PA shares.
Pfizer offers one of the highest dividend yields among blue-chip pharma companies. Post-COVID revenue normalization has pressured earnings, but the dividend has been maintained. Pfizer's acquisition of Seagen adds oncology depth. With 14+ consecutive years of no dividend cuts, income investors see the high yield as an opportunity.
Is ACP-PA or PFE better for dividend income in 2026?
ACP-PA currently offers a 4.00% yield (2.00/share/year) while PFE offers 6.77% (1.68/share/year). PFE provides higher current income. However, ACP-PA has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in ACP-PA vs PFE earn per year?
With $10,000 invested today: ACP-PA pays approximately $400/year. PFE pays approximately $677/year. With DRIP reinvestment over 10 years, these grow to $899/year (ACP-PA) and $5,820/year (PFE).
Does ACP-PA or PFE pay monthly dividends?
ACP-PA pays quarterly dividends. PFE pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this ACP-PA vs PFE comparison by email
Save your analysis + get weekly dividend insights. Free forever.